SOPH
Sophia Genetics SA
NASDAQ: SOPH · HEALTHCARE · HEALTH INFORMATION SERVICES
$5.28
+5.60% today
Updated 2026-04-29
Market cap
$358.34M
P/E ratio
—
P/S ratio
4.64x
EPS (TTM)
$-1.17
Dividend yield
—
52W range
$3 – $6
Volume
0.1M
Sophia Genetics SA (SOPH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-13.3%
Last 4 quarters
Revenue YoY growth
+22.4%
Most recent quarter
EPS YoY growth
-42.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-9.6%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $-0.17 | +22.4% | $4.62 | $4.23 | -8.5% |
| 2025-11-04 | $-0.30 | -30.4% | $5.00 | $4.52 | -9.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.22 | $-0.17 | +22.4% | $21.71M | +22.4% |
| 2025-09-30 | $-0.23 | $-0.30 | -30.4% | $19.46M | +22.8% |
| 2025-06-30 | $-0.22 | $-0.25 | -11.7% | $18.32M | +15.9% |
| 2025-03-31 | $-0.20 | $-0.26 | -33.4% | $17.78M | +12.7% |
| 2024-12-31 | $-0.15 | $-0.12 | +20.1% | $17.73M | +4.0% |
| 2024-09-30 | $-0.23 | $-0.28 | -20.8% | $15.85M | -2.8% |
| 2024-06-30 | $-0.28 | $-0.23 | +17.9% | $15.81M | +5.0% |
| 2024-03-31 | $-0.27 | $-0.21 | +22.2% | $15.78M | +13.0% |
| 2023-12-31 | $-0.27 | $-0.37 | -37.0% | $17.05M | — |
| 2023-09-30 | $-0.32 | $-0.21 | +34.4% | $16.30M | — |
| 2023-06-30 | $-0.31 | $-0.33 | -6.5% | $15.05M | — |
| 2023-03-31 | $-0.32 | $-0.31 | +3.1% | $13.97M | — |
Frequently asked questions
Has Sophia Genetics SA beaten earnings estimates?
Sophia Genetics SA has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -13.3% over the last 4 quarters.
How does SOPH stock react to earnings?
SOPH stock has moved an average of -9.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Sophia Genetics SA's revenue growth rate?
Sophia Genetics SA reported year-over-year revenue growth of +22.4% in its most recent quarter, with EPS growing -42.4% year-over-year.